Arkema: Statement About the Number of Shares and Voting Rights in Compliance With the Article L.233-8 II of the French Commercial Code and the Article 223-16 of the Financial Markets Authority (AMF-Autorité Des Marchés Financiers)

Why It Matters

Accurate share and voting‑right data are essential for investors assessing ownership concentration and voting power, influencing corporate governance decisions. The filing reinforces Arkema’s compliance posture, reducing regulatory risk and supporting market confidence.

Key Takeaways

• Total shares: 76.06 million
• Voting rights including company: 95.36 million
• Excluding company holdings: 94.97 million voting rights
• Compliance with French Commercial Code L.233‑8 II
• Disclosure required by AMF article 223‑16

Pulse Analysis

Regulatory transparency is a cornerstone of French capital markets, and Arkema’s latest filing illustrates how listed companies meet statutory obligations. Under article L.233‑8 II of the French Commercial Code and AMF article 223‑16, issuers must disclose the exact number of shares and voting rights, ensuring that shareholders have reliable data for voting and investment decisions. By publishing the March 31, 2026 figures, Arkema not only fulfills legal duties but also signals a commitment to clear governance practices, a factor that can affect analyst coverage and credit assessments.

The disclosed numbers reveal a robust equity base: 76.06 million shares outstanding and nearly 95.4 million voting rights, indicating that the company holds a modest portion of its own equity. The slight discrepancy between total voting rights and those held by external investors (94.97 million) suggests minimal treasury stock, limiting dilution risk for new investors. For shareholders, understanding the split between company‑held and free‑floating voting rights is critical when evaluating potential influence over strategic resolutions, board elections, and dividend policies.

From a market perspective, Arkema’s transparent reporting aligns it with peers in the diversified chemicals sector, where clear capital structure disclosures are increasingly scrutinized by ESG‑focused investors. Accurate share counts aid in calculating key metrics such as earnings per share and market capitalization, which in turn influence stock valuation. As the industry navigates supply‑chain volatility and sustainability mandates, firms that demonstrate rigorous compliance and openness are better positioned to attract capital and maintain stakeholder trust.